Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Sales | 120 | 99 | 70 | 12 | 9 |
| Cost of Goods | N/A | N/A | -2 | 7 | 6 |
| Gross Profit | N/A | N/A | 72 | 5 | 3 |
| Operating Expenses | 229 | -519 | 954 | 1,504 | 1,851 |
| Operating Income | -109 | 629 | -882 | -1,500 | -1,847 |
| Other Income | 14 | -11 | 1,340 | 229 | -20 |
| Pre-tax Income | -96 | 618 | 458 | -1,271 | -1,867 |
| Net Income Continuous | -96 | 618 | 458 | -1,271 | -1,867 |
| Net Income | $-96 | $-5,841 | $458 | $-1,271 | $-1,867 |
| EPS Basic Total Ops | -0.02 | -0.90 | 0.10 | -0.20 | -0.30 |
| EPS Basic Continuous Ops | -0.02 | 0.20 | 0.10 | -0.20 | -0.30 |
| EPS Diluted Total Ops | -0.02 | -0.90 | 0.10 | -0.20 | -0.30 |
| EPS Diluted Continuous Ops | -0.02 | 0.20 | 0.10 | -0.20 | -0.30 |
| EBITDA(a) | $-109 | $110 | $-725 | $-1,324 | $-1,659 |